Theoretical and experimental study of donor-bridge-acceptor system: model 2-[5-(9H-fluoren-9-…
into 70 cm3 water. The aqueous layer was filtered. The
crude product was recrystallized and purified by column
chromatography (hexane: EtOAc, 9:1).
137.3, 139.0, 139.1, 139.3, 141.6, 144.2, 160.1, 164.1 ppm;
~
and IR (KBr): m = 725, 740, 751, 768, 802, 823, 857, 1008,
1034, 1070, 1220, 1249, 1362, 1398, 1446, 1506, 1526,
1584, 3025 cm-1
.
2-[5-(9H-Fluoren-9-ylidenemethyl)thiophen-2-yl]-5-(thio-
phen-2-yl)-1,3,4-oxadiazole (FLOX1c, C24H14N2OS2)
Yield: 150 mg (60%); yellow powder; m.p.: 177–180 °C;
1H NMR (300 MHz, CDCl3): d = 7.18–7.20 (m, 1H),
7.27–7.39 (m, 4H), 7.44 (dd, 1H, J = 3.9 Hz), 7.51 (s, 1H),
7.58 (dd, 1H, J = 5.1 Hz), 7.65–7.73 (m, 3H), 7.79–7.82
(m, 2H), 8.05 (d, 1H, J = 7.8 Hz) ppm; 13C NMR
(75 MHz, CDCl3): d = 116.7, 119.4, 119.7, 120.2, 124.3,
124.4, 125.3, 126.8, 126.9, 128.0, 128.7, 129.2, 129.7,
129.9, 129.9, 130.2, 135.3, 138.4, 138.7, 138.9, 141.3,
2-[5-(9H-Fluoren-9-ylidenemethyl)thiophen-2-yl]-5-(3-
methylbenzofuran-2-yl)-1,3,4-oxadiazole
(FLOX4c,
C29H18N2O2S)
1
Yield: 70%; yellow powder; m.p.: 228–230 °C; H NMR
(300 MHz, CDCl3): d = 2.72 (s, 3H), 7.18–7.23 (m, 1H),
7.30–7.42 (m, 4H), 7.44–7.50 (m, 2H), 7.55 (s, 1H), 7.60
(d, 1H, J = 6.9 Hz), 7.66–7.77 (m, 4H), 7.91 (d, 1H,
J = 3.9 Hz), 8.05 (d, 1H, J = 7.8 Hz) ppm; 13C NMR
(75 MHz, CDCl3): d = 9.6, 110.1, 111.5, 116.9, 119.2,
121.0, 123.3, 124.1, 124.6, 124.9, 127.5, 128.2, 128.4,
128.7, 128.9, 129.4, 130.1, 130.2, 136.8, 137.4, 137.5,
140.2, 142.1, 151.3, 154.1, 157.5, 161.2 ppm; and IR
~
143.7, 159.6, 160.1 ppm; and IR (KBr): m = 706, 722, 775,
823, 855, 1024, 1035, 1062, 1353, 1444, 1485, 1574, 1617,
3074, 3104 cm-1
.
~
(KBr): m = 718, 736, 769, 828, 875, 1029, 1074, 1138,
1266, 1342, 1358, 1380, 1404, 1442, 1454, 1485, 1578,
2-[5-(9H-Fluoren-9-ylidenemethyl)thiophen-2-yl]-5-phe-
nyl-1,3,4-oxadiazole (FLOX2a, C26H16N2OS)
1616, 1634, 2922, 3073 cm-1
.
Yield: 155 mg (63%); yellow powder; m.p.: 168–169 °C;
1H NMR (300 MHz, CDCl3): d = 7.17–7.20 (m, 1H), 7.25
(s, 1H), 7.32-7.42 (m, 3H), 7.45–7.53 (m, 4H), 7.54–7.68
(m, 3H), 7.71 (s, 1H), 7.75 (d, 1H, J = 8.4 Hz), 7.87(d, 1H,
J = 3.9 Hz), 8.07 (d, 1H, J = 7.8 Hz) ppm; 13C NMR
(75 MHz, CDCl3): d = 116.9, 119.7, 119.9, 120.4, 123.5,
124.5, 126.9, 127.1, 127.2, 128.4, 128.8, 129.1, 129.2,
129.4, 130.1, 130.5, 131.8, 133.7, 134.5, 135.7, 139.2,
Optical spectroscopy and electrochemistry
The optical and electrochemical properties of synthesized
FLOXs were determined by UV–Vis absorption and cyclic
voltammetry measurements. The UV–VIS absorption
spectra were taken on a UV 1650PC spectrometer (Shi-
madzu, Japan). Dichloromethane (CH2Cl2) was used for
UV spectroscopy (Merck). The solution was measured in
1 cm cuvette. Fluorescence spectra were recorded on a
Perkin–Elmer MPF-4 spectrofluorimeter (Norfolk, Con-
necticut USA). The cyclic voltammetry measurements
were performed in solution, under nitrogen atmosphere
with a computer-controlled electrochemical workstation
(Amel 2053) in a three electrode single-compartment cells
using platinum electrodes and SCE as the standard elec-
trode, with ferrocene/ferricinium (Fc/Fc?) redox couple as
internal standard, with a tetrabutylammonium tetrafluo-
roborate solution (0.1 M) in dichloromethane at a scan rate
of 50 mV s-1. The electric potential for ferrocene oxida-
tion versus the standard hydrogen electrode E(Fc?/Fc) was
0.64 V.
~
141.6, 144.1, 162.3, 171.9 ppm; and IR (KBr): m = 686,
717, 729, 776, 857, 1025, 1066, 1274, 1352, 1447, 1486,
1547, 1582, 3051 cm-1
.
4-[5-[5-(9H-Fluoren-9-ylidenemethyl)thiophen-2-yl]-
1,3,4-oxadiazol-2-yl]-N,N-dimethylaniline
(FLOX2c,
C28H21N3OS)
Yield: 141 mg (52%); yellow powder; m.p.: 150–152 °C;
1H NMR (300 MHz, CDCl3): d = 3.06 (s, 6H), 7.01 (s,
1H), 7.05-7.10 (m, 2H), 7.36–7.39 (m, 4H), 7.44 (dd, 1H,
J = 3.9 Hz), 7.61–7.63 (m, 3H), 7.72–7.73 (m, 3H), 8.28
(d, 1H, J = 7.8 Hz) ppm; and 13C NMR (75 MHz,
CDCl3): d = 41.3, 116.7, 119.4, 119.7, 121.0, 124.1,
124.4, 127.5, 128.4, 128.5, 128.7, 130.1, 136.8, 137.4,
137.5, 137.6, 140.2, 142.1, 155.3, 161.2, 164.5 ppm.
2-[5-(9H-Fluoren-9-ylidenemethyl)thiophen-2-yl]-5-(naph-
thalen-2-yl)-1,3,4-oxadiazole (FLOX3c, C30H18N2OS)
Yield: 199 mg (72%); yellow powder; m.p.: 186–188 °C;
1H NMR (300 MHz, CDCl3): d = 7.21 (t, 1H,
J = 5.7 Hz), 7.31–7.42 (m, 3H), 7.50–7.51 (m, 1H), 7.57
(s, 1H), 7.61–7.65 (m, 2H), 7.70–7.77 (m, 3H), 7.93 (d, 1H,
J = 3.0 Hz), 7.96 (d, 3H, J = 6.0 Hz), 8.05–8.09 (m, 2H),
8.28 (d, 1H, J = 5.5 Hz) ppm; 13C NMR (75 MHz,
CDCl3): d = 116.9, 119.8, 120.0, 120.2, 120.5, 124.6,
124.9, 125.9, 126.2, 126.8, 127.1, 127.2, 128.2, 128.4,
128.7, 128.9, 129.4, 130.0, 130.2, 132.7, 133.8, 135.7,
Quantum chemical calculations
All quantum chemical calculations were done using the
Gaussian 09 program package [24]. The optimal electronic
ground-state geometries were found at the density func-
tional level of theory employing Becke’s three parameter
hybrid functional using the Lee, Yang, and Parr correlation
functions (B3LYP) [25, 26]. For the all-anti conformations,
the initial setting of dihedral angle between thiophene and
oxadiazole rings was ?150°, and the dihedral angle
123